Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) Asset Utilization Ratio (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Asset Utilization Ratio for 2 consecutive years, with 0.47 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 1353.05% to 0.47 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.47 through Dec 2025, up 1353.05% year-over-year, with the annual reading at 0.0 for FY2023, N/A changed from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.47 at Neuphoria Therapeutics, down from 0.56 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.64 in Q1 2025, with the low at 0.03 in Q4 2024.